The cost to global health of drug company profits.
作者信息
MacDonald R, Yamey G
出版信息
West J Med. 2001 May;174(5):302-3. doi: 10.1136/ewjm.174.5.302.
Abstract
摘要
相似文献
1
The cost to global health of drug company profits.
West J Med. 2001 May;174(5):302-3. doi: 10.1136/ewjm.174.5.302.
2
Drug company "honoraria".
Arthritis Rheum. 1989 Nov;32(11):1490. doi: 10.1002/anr.1780321126.
3
A chemical reaction. Abbott CEO concocts high profits for company.
Mod Healthc. 1988 Aug 19;18(34):48.
4
Spain's drug industry agrees to ethical drug promotion behaviour.
Lancet. 2002 Jun 1;359(9321):1926. doi: 10.1016/S0140-6736(02)08792-5.
5
Drug company sponsorship of education could be replaced at a fraction of its cost.
BMJ. 2003 May 31;326(7400):1163. doi: 10.1136/bmj.326.7400.1163.
6
Revitalizing pharmaceutical innovation for global health.
Health Aff (Millwood). 2011 Feb;30(2):367. doi: 10.1377/hlthaff.2011.0103.
7
Perspectives. Wanna lower health costs? Don't look to drug profits.
Med Health. 2001 Apr 9;55(15):suppl 2 p..
8
Pharmaceuticals and the health of the public: use, safety, cost, access, ethics, and quality.
Med Care. 2012 Nov;50(11):907-9. doi: 10.1097/MLR.0b013e3182733b57.
9
Drug firm support of American Medical Association ethics effort draws fire.
Lancet. 2001 Sep 8;358(9284):821. doi: 10.1016/S0140-6736(01)06021-4.
10
Guidelines for pharmaceutical company gifts.
Fam Med. 1991 May-Jun;23(4):249, 253.
引用本文的文献
1
On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa.
Global Health. 2014 Sep 25;10:70. doi: 10.1186/s12992-014-0070-z.
2
The world's most neglected diseases.
BMJ. 2002 Jul 27;325(7357):176-7. doi: 10.1136/bmj.325.7357.176.
3
Africa can solve its own health problems.
BMJ. 2002 Mar 23;324(7339):688-9. doi: 10.1136/bmj.324.7339.688.
本文引用的文献
1
US trade action threatens Brazilian AIDS programme.
BMJ. 2001 Feb 17;322(7283):383.
2
Tropical medicine.
BMJ. 2000 Feb 19;320(7233):490-4. doi: 10.1136/bmj.320.7233.490.
3
US changes trade policy on essential medicines.
BMJ. 1999 Dec 11;319(7224):1521. doi: 10.1136/bmj.319.7224.1521.
4
Access to essential drugs in poor countries: a lost battle?
JAMA. 1999 Jan 27;281(4):361-7. doi: 10.1001/jama.281.4.361.
Zotero 插件